Blood | American Society of Hematology

Skip Nav Destination

Current Issue

Volume 146,

Issue 4,

July 24 2025

View This Issue

Issue Highlights

Integrin αIIbβ3 mediates ChAdOx1-platelet binding
Itacitinib prophylaxis against CRS during CAR-T therapy
Postimmunotherapy lineage switch in B-ALL
EBF1 modulates inotuzumab sensitivity
MPL dependency of Jak2 V617F phenotypes in vivo
Review: breakthrough hemolysis in PNH

Latest in Blood

Free Articles

Targeting B-cell identity: how EBF1 modulates InO response

Lorenz Bastian

https://doi.org/10.1182/blood.2025029476

View All Free Articles

Plenary Papers

HNRNPC and m 6 A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia

Jonas De Kesel; Igor Fijalkowski; Tim Pieters; Cristina Borin; Kasper Thorhauge Christensen; Manou Wittouck; Jolien Van Laere; Laura Guerrero; Lindy Reunes; Marino Caruso; Bijal Thakkar; Wouter Sleeckx; Luyao Kevin Xu; Filip Van Nieuwerburgh; Dieter Deforce; Kim De Keersmaecker; Tim Lammens; Steven Goossens; Tom Taghon; Cuijuan Han; Giulia Veltri; Valentina Serafin; Bruno Palhais; Nitesh D. Sharma; Hao Huang; Hudan Liu; Ksenia Matlawska-Wasowska; Ana Milovanovic; Eva Maria Novoa; Eric Wang; Panagiotis Ntziachristos

https://doi.org/10.1182/blood.2024026848

View All Plenary Papers

First Edition

Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain Amyloidosis

Pedro Vianna; Rajshekhar Chakraborty; Shahrier Hossain; Divaya Bhutani; Shannon Miller; Annemarie Rossi; Sarah AM Cuddy; Rodney H Falk; Suzanne Lentzsch; Jacob Laubach; Giada Bianchi

https://doi.org/10.1182/blood.2025028383

View All First Edition Articles

Clinical Trials and Observations

Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial

Jing Pan; Liping Zhao; Yibing Zhang; Samuel Seery; Yue Tan; Biping Deng; Lingling Shan; Zhuojun Ling; Fan Wu; Quangang Wang; Xinjian Yu; Qinlong Zheng; Xiuwen Xu; Ying Yuan; Zhenglong Tian; Yanlei Zhang; Shuixiu Peng; Alex H. H. Chang; Xiaoming Feng

https://doi.org/10.1182/blood.2025029299

View All Clinical Trials and Observations

Advertisement intended for health care professionals

Over 165,000 citations
earned in 2024

ASH Commitment to Expansion and Inclusion in Hematology

Acknowledgement of Reviewers for 2024

Issue Highlights

Over 165,000 citations
earned in 2024

Featured Content

Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study

Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosis

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Delineating Mpl-dependent and -independent phenotypes of Jak2 V617F–positive MPNs in vivo

NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma

Relationship between immunogenicity and protein structure at amino acid substitution sites of blood group antigens

ASH Publications

American Society of Hematology

Issue Highlights

Over 165,000 citations earned in 2024

Featured Content

Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study

Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosis

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Delineating Mpl-dependent and -independent phenotypes of Jak2 V617F–positive MPNs in vivo

NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma

Relationship between immunogenicity and protein structure at amino acid substitution sites of blood group antigens

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

Over 165,000 citations
earned in 2024